Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Advanced NanoTherapies.

    Client Virtual Booth

    ADVANCED NANOTHERAPIES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Advanced NanoTherapies
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    16185 Los Gatos Blvd Suite 205-31 Los Gatos, California 95032
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://advnanot.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/advanced-nanotherapies/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Advanced NanoTherapies (ANT) Secures $4M Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating D...

    Details:

    The financing will be used to accelerate clinical development of next-generation SirPlux duo drug-coated balloon (DCB) which combines the synergistic power of sirolimus and paclitaxel to create a next-generation, front-line therapy for treating de novo coronary artery disease.


    Lead Product(s): Sirolimus,Paclitaxel

    Therapeutic Area: Cardiology/Vascular Diseases Product Name: SirPlux Duo DCB

    Highest Development Status: PreclinicalProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Undisclosed

    Deal Size: $4.0 million Upfront Cash: Undisclosed

    Deal Type: Series A Financing August 22, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing

    Details:

    Funds will be used to complete the first-in-human clinical study in Australia of the SirPlux Duo (paclitaxel and sirolimus) drug-coated balloon (DCB) in de-novo coronary artery disease (CAD) lesions.


    Lead Product(s): Paclitaxel,Sirolimus

    Therapeutic Area: Cardiology/Vascular Diseases Product Name: SirPlux Duo

    Highest Development Status: PreclinicalProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Undisclosed

    Deal Size: $7.2 million Upfront Cash: Undisclosed

    Deal Type: Series A Financing June 28, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    minakem-m-2024-05-27

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search